The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Colistin Update on Its Mechanism of Action and Resistance, Present and Future Challenges
Open accessAbstract
Colistin has been extensively used since the middle of the last century in animals, particularly in swine, for the control of enteric infections. Colistin is presently considered the last line of defense against human infections caused by multidrug-resistant Gram-negative organisms such as carbapenemase-producer Enterobacterales, Acinetobacter baumanni, and Pseudomonas aeruginosa. Transferable bacterial resistance like mcr-genes was reported in isolates from both humans and animals. Researchers actively seek strategies to reduce colistin resistance. The definition of guidelines for colistin therapy in veterinary and human medicine is thus crucial. The ban of colistin use in swine as a growth promoter and for prophylactic purposes, and the implementation of sustainable measures in farm animals for the prevention of infections, would help to avoid resistance and should be encouraged. Colistin resistance in the human–animal–environment interface stresses the relevance of the One Health approach to achieve its effective control. Such measures should be addressed in a cooperative way, with efforts from multiple disciplines and with consensus among doctors, veterinary surgeons, and environment professionals. A revision of the mechanism of colistin action, resistance, animal and human use, as well as colistin susceptibility evaluation is debated here.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liu, Y.-Y., Wang, Y., Walsh, T. R., Yi, L.-X., Zhang, R., Spencer, J., Doi, Y., Tian, G., Dong, B., Huang, X., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00424-7 · Cited by 5,398
Falagas, M. E., Kasiakou, S. K., & Saravolatz, L. D. (2005) · Clinical Infectious Diseases · doi:10.1086/429323 · Cited by 1,744
Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria
Olaitan, A. O., Morand, S., & Rolain, J.-M. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00643 · Cited by 1,395
Tsuji, B. T., Pogue, J. M., Zavascki, A. P., Paul, M., Daikos, G. L., Forrest, A., Giacobbe, D. R., Viscoli, C., Giamarellou, H., Karaiskos, I., et al. (2019) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2209 · Cited by 949
Moffatt, J. H., Harper, M., Harrison, P., Hale, J. D. F., Vinogradov, E., Seemann, T., Henry, R., Crane, B., St. Michael, F., Cox, A. D., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00834-10 · Cited by 812
Pruden, A., Larsson, D. G. J., Amézquita, A., Collignon, P., Brandt, K. K., Graham, D. W., Lazorchak, J. M., Suzuki, S., Silley, P., Snape, J. R., et al. (2013) · Environmental Health Perspectives · doi:10.1289/ehp.1206446 · Cited by 806
Structure−Activity Relationships of Polymyxin Antibiotics
Velkov, T., Thompson, P. E., Nation, R. L., & Li, J. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm900999h · Cited by 780
Xavier, B. B., Lammens, C., Ruhal, R., Kumar-Singh, S., Butaye, P., Goossens, H., & Malhotra-Kumar, S. (2016) · Eurosurveillance · doi:10.2807/1560-7917.es.2016.21.27.30280 · Cited by 779
Garonzik, S. M., Li, J., Thamlikitkul, V., Paterson, D. L., Shoham, S., Jacob, J., Silveira, F. P., Forrest, A., & Nation, R. L. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01733-10 · Cited by 696
Rebelo, A. R., Bortolaia, V., Kjeldgaard, J. S., Pedersen, S. K., Leekitcharoenphon, P., Hansen, I. M., Guerra, B., Malorny, B., Borowiak, M., Hammerl, J. A., et al. (2018) · Eurosurveillance · doi:10.2807/1560-7917.es.2018.23.6.17-00672 · Cited by 669
de Jonge, E., Schultz, M. J., Spanjaard, L., Bossuyt, P. M., Vroom, M. B., Dankert, J., & Kesecioglu, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14409-1 · Cited by 587
Colistin: an update on the antibiotic of the 21st century
Biswas, S., Brunel, J.-M., Dubus, J.-C., Reynaud-Gaubert, M., & Rolain, J.-M. (2012) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.12.78 · Cited by 581
Fortifying the barrier: the impact of lipid A remodelling on bacterial pathogenesis
Needham, B. D., & Trent, M. S. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro3047 · Cited by 565
Carroll, L. M., Gaballa, A., Guldimann, C., Sullivan, G., Henderson, L. O., & Wiedmann, M. (2019) · mBio · doi:10.1128/mbio.00853-19 · Cited by 506
Novel plasmid-mediated colistin resistance gene mcr-7.1 in Klebsiella pneumoniae
Yang, Y.-Q., Li, Y.-X., Lei, C.-W., Zhang, A.-Y., & Wang, H.-N. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky111 · Cited by 367
Innovative and rapid antimicrobial susceptibility testing systems
van Belkum, A., Burnham, C.-A. D., Rossen, J. W. A., Mallard, F., Rochas, O., & Dunne, W. M. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-020-0327-x · Cited by 355
Transferable resistance to colistin: a new but old threat: Table 1.
Schwarz, S., & Johnson, A. P. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw274 · Cited by 314
The mgrB gene as a key target for acquired resistance to colistin in Klebsiella pneumoniae
Poirel, L., Jayol, A., Bontron, S., Villegas, M.-V., Ozdamar, M., Turkoglu, S., & Nordmann, P. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku323 · Cited by 302
Resistance to polymyxins: Mechanisms, frequency and treatment options
Falagas, M. E., Rafailidis, P. I., & Matthaiou, D. K. (2010) · Drug Resistance Updates · doi:10.1016/j.drup.2010.05.002 · Cited by 298
Falgenhauer, L., Waezsada, S.-E., Yao, Y., Imirzalioglu, C., Käsbohrer, A., Roesler, U., Michael, G. B., Schwarz, S., Werner, G., Kreienbrock, L., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)00009-8 · Cited by 282
A new strategy to fight antimicrobial resistance: the revival of old antibiotics
Cassir, N., Rolain, J.-M., & Brouqui, P. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00551 · Cited by 280
Management of carbapenem-resistant Enterobacteriaceae infections
Durante-Mangoni, E., Andini, R., & Zampino, R. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.04.013 · Cited by 261
Co-occurrence of extended spectrum β lactamase and MCR-1 encoding genes on plasmids
Haenni, M., Poirel, L., Kieffer, N., Châtre, P., Saras, E., Métayer, V., Dumoulin, R., Nordmann, P., & Madec, J.-Y. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)00007-4 · Cited by 256
Strategies for bypassing the membrane barrier in multidrug resistant Gram‐negative bacteria
Bolla, J.-M., Alibert-Franco, S., Handzlik, J., Chevalier, J., Mahamoud, A., Boyer, G., Kieć-Kononowicz, K., & Pagès, J.-M. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.04.054 · Cited by 250
Deris, Z. Z., Akter, J., Sivanesan, S., Roberts, K. D., Thompson, P. E., Nation, R. L., Li, J., & Velkov, T. (2014) · The Journal of Antibiotics · doi:10.1038/ja.2013.111 · Cited by 216
Silvestri, L., van Saene, H. K. F., Milanese, M., Gregori, D., & Gullo, A. (2007) · Journal of Hospital Infection · doi:10.1016/j.jhin.2006.10.014 · Cited by 208
Plasmid-mediated carbapenem and colistin resistance in a clinical isolate of Escherichia coli
Poirel, L., Kieffer, N., Liassine, N., Thanh, D., & Nordmann, P. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)00006-2 · Cited by 208
Lu, Q., Luo, R., Bodin, L., Yang, J., Zahr, N., Aubry, A., Golmard, J.-L., & Rouby, J.-J. (2012) · Anesthesiology · doi:10.1097/aln.0b013e31827515de · Cited by 207
Lee, G. C., & Burgess, D. S. (2012) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/1476-0711-11-32 · Cited by 199
Clinical Pharmacokinetics and Pharmacodynamics of Colistin
Grégoire, N., Aranzana-Climent, V., Magréault, S., Marchand, S., & Couet, W. (2017) · Clinical Pharmacokinetics · doi:10.1007/s40262-017-0561-1 · Cited by 191
Halaby, T., al Naiemi, N., Kluytmans, J., van der Palen, J., & Vandenbroucke-Grauls, C. M. J. E. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02634-12 · Cited by 182
International cooperation to improve access to and sustain effectiveness of antimicrobials
Årdal, C., Outterson, K., Hoffman, S. J., Ghafur, A. K., Sharland, M., Ranganathan, N., Smith, R., Zorzet, A., Cohn, J., Pittet, D., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00470-5 · Cited by 159
Resistance to colistin: what is the fate for this antibiotic in pig production?
Rhouma, M., Beaudry, F., & Letellier, A. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.04.008 · Cited by 159
Possible Transmission ofmcr-1–HarboringEscherichia colibetween Companion Animals and Human
Zhang, X.-F., Doi, Y., Huang, X., Li, H.-Y., Zhong, L., Zeng, K.-J., Zhang, Y.-F., Patil, S., & Tian, G. (2016) · Emerging infectious diseases · doi:10.3201/eid2209.160464 · Cited by 153
Colistin-resistant Escherichia coli harbouring mcr-1 isolated from food animals in Hanoi, Vietnam
Malhotra‐Kumar, S., Xavier, B. B., Das, A. J., Lammens, C., Hoang, H. T. T., Ngoc, P. T., & Goossens, H. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)00014-1 · Cited by 143
Colistin resistance inSalmonellaandEscherichia coliisolates from a pig farm in Great Britain
Anjum, M. F., Duggett, N. A., AbuOun, M., et al. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw149 · Cited by 140
Activity and Predicted Nephrotoxicity of Synthetic Antibiotics Based on Polymyxin B
Gallardo‐Godoy, A., Muldoon, C. A., Becker, B., Elliott, A. G., Lash, L. H., Huang, J. X., Butler, M. S., Pelingon, R., Kavanagh, A. M., Ramu, S., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01593 · Cited by 138
Colistin for lung infection: an update
Gurjar, M. (2015) · Journal of Intensive Care · doi:10.1186/s40560-015-0072-9 · Cited by 135
Chen, J., Michel, F. C., Sreevatsan, S., Morrison, M., & Yu, Z. (2010) · Microbial Ecology · doi:10.1007/s00248-010-9634-5 · Cited by 108
Burow, E., Rostalski, A., Harlizius, J., Gangl, A., Simoneit, C., Grobbel, M., Kollas, C., Tenhagen, B., & Käsbohrer, A. (2019) · Preventive Veterinary Medicine · doi:10.1016/j.prevetmed.2019.02.008 · Cited by 98
Re-emergence of colistin in today's world of multidrug-resistant organisms: personal perspectives
Falagas, M. E., & Rafailidis, P. I. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.7.973 · Cited by 70
López‐Camacho, E., Gómez-Gil, R., Tobes, R., Manrique, M., Lorenzo, M., Galván, B., Salvarelli, E., Moatassim, Y., Salanueva, Í. J., Pareja, E., et al. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt419 · Cited by 70
Trauffler, M., Griesbacher, A., Fuchs, K., & Köfer, J. (2014) · Veterinary Record · doi:10.1136/vr.102520 · Cited by 67
Brink, A. J., Richards, G. A., Colombo, G., Bortolotti, F., Colombo, P., & Jehl, F. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.06.013 · Cited by 53
Tsuji, B. T., Landersdorfer, C. B., Lenhard, J. R., Cheah, S.-E., Thamlikitkul, V., Rao, G. G., Holden, P. N., Forrest, A., Bulitta, J. B., Nation, R. L., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02831-15 · Cited by 51
Optimizing Polymyxin Combinations Against Resistant Gram-Negative Bacteria
Bergen, P. J., Bulman, Z. P., Landersdorfer, C. B., Smith, N. M., Lenhard, J. R., Bulitta, J. B., Nation, R. L., Li, J., & Tsuji, B. T. (2015) · Infectious Diseases and Therapy · doi:10.1007/s40121-015-0093-7 · Cited by 49
High Prevalence of oqx AB in Escherichia coli Isolates from Domestic and Wild Lagomorphs in Italy
Dotto, G., Giacomelli, M., Grilli, G., Ferrazzi, V., Carattoli, A., Fortini, D., & Piccirillo, A. (2013) · Microbial Drug Resistance · doi:10.1089/mdr.2013.0141 · Cited by 39
Devendec, L. L., Mourand, G., Bougeard, S., Léaustic, J., Jouy, É., Keïta, A., Couet, W. R., Rousset, N., & Kempf, I. (2015) · Veterinary Microbiology · doi:10.1016/j.vetmic.2015.11.012 · Cited by 37
Ly, N. S., Yang, J. C., Bulitta, J. B., & Tsuji, B. T. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06380-11 · Cited by 36
Silva, D. F. E., Silva-Dias, A., Gomes, R., Martins-Oliveira, I., Ramos, M. H., Rodrigues, A. G., Cantón, R., & Pina‐Vaz, C. (2019) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2019.08.016 · Cited by 36
Self-citationColistin in burn intensive care: Back to the future?
Azzopardi, E., Boyce, D. E., Thomas, D. W., & Dickson, W. A. (2012) · Burns · doi:10.1016/j.burns.2012.07.015 · Cited by 30
Selective Digestive Decontamination Is Neither Safe Nor Efficacious for Critically Ill Patients
Hurley, J. C. (2019) · Critical Care Medicine · doi:10.1097/ccm.0000000000004047 · Cited by 12
Selective Decontamination Is Safe and Efficacious for Critically Ill Patients
Bonten, M. J. M. (2020) · Critical Care Medicine · doi:10.1097/ccm.0000000000004237 · Cited by 6
Antimicrobial Resistance: A One Health Concept Perspective Analysis
(2018) · Infectious Diseases Diagnosis & Treatment · doi:10.29011/2577-1515.100027 · Cited by 3
Cited by
Molecular mechanisms of antibiotic resistance revisited
Darby, E. M., Trampari, E., Siasat, P., Gaya, M. S., Alav, I., Webber, M. A., & Blair, J. M. A. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00820-y · Cited by 1,398
Metadata
- Authors
- Andrade, F. F., Silva, D., Rodrigues, A., & Pina-Vaz, C.
- Venue
- Microorganisms
- Publisher
- MDPI AG
- Published
- 2020-11-02
- Volume
- 8
- Issue
- 11
- Pages
- 1716
- ISSN
- 2076-2607 (ISSN-L)
- OpenAlex
- W3096406157
- Cited by
- 284
- References
- 54
- FWCI
- 8.94
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.